Literature DB >> 8073834

Lipoprotein peroxidation in adult psoriatic patients.

A M Offidani1, G Ferretti, M Taus, O Simonetti, N Dousset, P Valdiguie, G Curatola, G Bossi.   

Abstract

Psoriasis, a chronic inflammatory skin disease characterized by an aberration of lipid metabolism, has been associated with an increased risk for atherosclerosis. Since oxidatively modified lipoproteins are involved in the pathogenesis of atherosclerosis, we investigated the lipid composition and in vitro induced peroxidation of very low density lipoproteins (VLDL) and low density lipoproteins (LDL) from psoriatic patients. 11 male adult psoriatics and 16 male age-matched healthy subjects were studied. Lipid peroxidation of VLDL and LDL was performed by incubation with CuSO4 for 24 h at 37 degrees C. The compositional analysis showed a significant increase in triglycerides and phospholipids, both in VLDL (p < 0.05) and in LDL (p < 0.001) from psoriatic patients, compared with controls. Moreover a significant increase in total cholesterol (TC) (p < 0.01) and apoprotein (P) (p < 0.05) was found in LDL from psoriatics. The levels of thiobarbituric acid reactive substances (TBARS), as a measurement of lipid peroxidation, were significantly higher in Ox-VLDL and in Ox-LDL from psoriatics (p < 0.01) than the corresponding values in controls. Moreover, basal values of TBARS were significantly higher in VLDL and LDL from psoriatic patients than those from controls. In conclusion, the lipoprotein compositional changes associated with the modifications of TBARS before and after Cu2+ treatment of lipoproteins may suggest an increased risk for atherosclerosis in adult psoriatic patients.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8073834

Source DB:  PubMed          Journal:  Acta Derm Venereol Suppl (Stockh)        ISSN: 0365-8341


  6 in total

Review 1.  Non-alcoholic fatty liver disease and psoriasis: So far, so near.

Authors:  Giulia Ganzetti; Anna Campanati; Annamaria Offidani
Journal:  World J Hepatol       Date:  2015-03-27

Review 2.  Psoriasis, non-alcoholic fatty liver disease, and cardiovascular disease: Three different diseases on a unique background.

Authors:  Giulia Ganzetti; Anna Campanati; Elisa Molinelli; Annamaria Offidani
Journal:  World J Cardiol       Date:  2016-02-26

3.  Oxidative Stress and Alterations of Paraoxonases in Atopic Dermatitis.

Authors:  Oriana Simonetti; Tiziana Bacchetti; Gianna Ferretti; Elisa Molinelli; Giulio Rizzetto; Luisa Bellachioma; Annamaria Offidani
Journal:  Antioxidants (Basel)       Date:  2021-04-28

Review 4.  Cardiometabolic risk in psoriasis: differential effects of biologic agents.

Authors:  Mariana J Kaplan
Journal:  Vasc Health Risk Manag       Date:  2008

5.  Gene polymorphisms of TNF-238G/A, TNF-308G/A, IL10-1082G/A, TNFAIP3, and MC4R and comorbidity occurrence in a Romanian population with psoriasis.

Authors:  Vlad Mihai Voiculescu; Iulia Solomon; Alexandra Popa; Carmen Cristina Draghici; Maria Dobre; Calin Giurcaneanu; Laura Maria Lucia Papagheorghe; Mihai Lupu
Journal:  J Med Life       Date:  2018 Jan-Mar

6.  Treatment of Moderate-to-Severe Psoriasis in the Presence of Kaposi's Varicelliform Eruption.

Authors:  Anna Campanati; Elisa Molinelli; Valerio Brisigotti; Donatella Brancorsini; Ivan Bobyr; Federico Diotallevi; Giulia Radi; Annamaria Offidani
Journal:  Case Rep Dermatol       Date:  2019-09-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.